Researchers evaluated the impact of menopausal hormone therapy on cardiovascular disease risk among women in midlife experiencing vasomotor symptoms.

Those who received vs did not receive SSRIs before and after sleeve gastrectomy had limited total weight loss at 1 year.

Leo Anzivino Jr., 35, of Falmouth, Massachusetts, pleaded guilty Tuesday in federal court in Concord, New Hampshire, to one count of money laundering conspiracy, the U.S. Attorney’s Office for the ...

(HealthDay News) — Structured support may attenuate weight gain after cessation of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), according to a study published online Oct. 7 in Obesity ...

Class I obesity at incident dementia linked to 27 percent lower risk for mortality compared with normal weight ...

After multivariable adjustment, skipping breakfast and variable meal frequencies were not linked to MASLD, cirrhosis ...

In insulin-naive adults with T2D, once-weekly icodec plus semaglutide vs insulin glargine U100 showed superior glycemic control and weight loss.

Robert Kauffman, MD, discusses the updated ACOG clinical guidance outlining pharmacologic and nonpharmacologic interventions for menopausal symptoms.

The FDA has approved Enspryng (satralizumab-mwge) for thyroid eye disease in adults, offering the first at-home subcutaneous IL-6 receptor antagonist for TED.

For adults taking potassium-raising medications, greater consumption of dietary potassium as part of a DASH diet is not associated with hyperkalemia.

The amylin-based analog petrelintide achieves meaningful weight reduction for adults with obesity, according to a study.